Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 1:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1633–1656 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Hypertension, Hypertension Complicated With Type 2 Diabetes
Interventions: iTHRIVE intervention, Active comparator; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Baltimore, Maryland • Gaithersburg, Maryland

Conditions: Vitamin D Deficiency, Hypertension
Interventions: Aliskiren, Cholecalciferol, Placebo; Drug · Dietary Supplement
Lead sponsor: UConn Health; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Glaucoma, Glaucoma, Open Angle
Interventions: SOLX Gold Shunt; Device
Lead sponsor: SOLX, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 11
States / cities: Birmingham, Alabama • Springdale, Arkansas • Irvine, California + 8 more

Conditions: Hypertension
Interventions: Practice Facilitation, Non-Practice Facilitation; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: Pulmonary Arterial Hypertension
Interventions: Not listed
Lead sponsor: Jeffrey A. Feinstein; Other
Eligibility: Up to 18 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hypertension
Interventions: LCZ696, Valsartan, AHU377, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1,334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 38
States / cities: Birmingham, Alabama • Muscle Shoals, Alabama • Chandler, Arizona + 30 more

Conditions: Hypertension, Vitamin D Deficiency
Interventions: Cholecalciferol; Drug
Lead sponsor: Loyola University; Other
Eligibility: 25 Years to 45 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Hypertension, Pulmonary
Interventions: bosentan, Pioglitazone; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Primary Open-Angle Glaucoma, Ocular Hypertension
Interventions: Bimatoprost; Drug
Lead sponsor: ForSight Vision5, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 9
States / cities: Fayetteville, Arkansas • Artesia, California • Newport Beach, California + 6 more

Conditions: Obstructive Sleep Apnea, Stroke, Transient Ischemic Attack, Hypertension
Interventions: CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA); Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: West Haven, Connecticut • Indianapolis, Indiana

Conditions: Pregnancy Toxemia, Hypertension, Proteinuria
Interventions: methyldopa, labetalol, nifedipine, clonidine; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Arterial Hypertension
Interventions: ubenimex; Drug
Lead sponsor: Eiger BioPharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 26
States / cities: Beverly Hills, California • La Jolla, California • Palo Alto, California + 20 more

Conditions: Chronic Kidney Disease, Hypertension
Interventions: Coaching DASH group (C-DASH), Self-Shopping DASH group (S-DASH); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 100 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension
Interventions: valsartan/amlodipine; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Medication Adherence, Habits, Hypertension
Interventions: Wellth app, Habit training; Other · Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cardiovascular Diseases, Heart Diseases, Hypertension
Interventions: Patient-centered Counseling; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 21 Years to 100 Years
Enrollment: 870 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Thromboembolic Pulmonary Hypertension, CTEPH
Interventions: Not listed
Lead sponsor: International CTEPH Association; Other
Eligibility: Not listed
Enrollment: 1,019 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 3
States / cities: La Jolla, California • Baltimore, Maryland • Cleveland, Ohio

Conditions: Glaucoma, Glaucoma, Open-Angle
Interventions: Hydrus Microstent, Incisional goniotomy, Excisional goniotomy; Procedure
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 40 Years to 85 Years
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prehypertension
Interventions: DASH; Other
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary; Hypertension, Heart Failure, Preserved Ejection Fraction
Interventions: 15N Nitrate, 14N Nitrate; Drug
Lead sponsor: Gladwin, Mark, MD; Individual
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Open Angle Glaucoma
Interventions: Combined cataract surgery with Hydrus microstent, Combined cataract surgery with iStent Inject W; Device
Lead sponsor: Diablo Eye Associates; Industry
Eligibility: 60 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Hypertension
Interventions: Bosentan, Placebo; Drug
Lead sponsor: Augusta University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Diabetes Mellitus, Type 2, Hypertension
Interventions: Inspiratory muscle strength training (IMST); Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Glaucoma
Interventions: Glaucoma screening with optical coherence tomography (OCT), color fundus photography, and tonometry, Educational Brochure; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Fremont, California • Oakland, California • San Francisco, California

Search by objective public record fields.

Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure

Vitamin D Deficiency in Patients With Hypertension

SOLX Gold Shunt for Refractory Glaucoma

Community Intervention to Reduce CardiovascuLar Disease in Chicago

Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)

Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study

Insulin Resistance in Pulmonary Arterial Hypertension

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease

Treatment Targets for Chronic Hypertension in Pregnancy

Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Five, Plus Nuts and Beans for Kidneys

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Habitual Hypertension Medication Adherence in Arizona

Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence

New International CTEPH Database

A Trial of Hydrus Microstent Versus Goniotomy

When the Kidney Reacts to Nutritional Changes

A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction

Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma

Endothelin Receptor Function and Acute Stress

Inspiratory Muscle Strength Training in Adults With Type 2 Diabetes

Glaucoma Screening to Enhance At-Risk Californians' Health